Heart transplantation for congenital heart disease in the first year of life

Current Cardiology Reviews

Volumn 7, Issue 2, 2011, Pages 72-84

  Chinnock, Richard E ^a   Bailey, Leonard L ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical outcome; Congenital heart disease; Donor issues; Hypoplastic left heart syndrome; Indications for transplant; Infant heart transplant

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AIR CONDITIONING; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CAUSE OF DEATH; CAVOPULMONARY CONNECTION; CHILD RESTRAINT SYSTEM; CHRONIC KIDNEY DISEASE; CONGENITAL HEART DISEASE; EXTRACORPOREAL OXYGENATION; FONTAN PROCEDURE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFANT DISEASE; KIDNEY FUNCTION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NEWBORN MORTALITY; NONHUMAN; NORWOOD PROCEDURE; ORGAN DONOR; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SLEEP; STERNOTOMY; SUDDEN INFANT DEATH SYNDROME; SURGICAL TECHNIQUE; THYMUS FUNCTION;

AGE FACTORS; CALIFORNIA; CAUSE OF DEATH; GRAFT REJECTION; GRAFT SURVIVAL; HEART DEFECTS, CONGENITAL; HEART DISEASES; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; LYMPHOMA; TISSUE DONORS;

EID: 80054096244     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340311797484231     Document Type: Article

References (48)

1. Bailey LL. The evolution of infant heart transplantation. J Heart Lung Transplant 2009; 28: 1241-45.
2. International Society for Heart and Lung Transplantation. Reference available from: www.ishlt.org/downloadables/slides/2010/heart_pediatric.ppt
3. Kirk R, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: Thirteenth official pediatric heart transplantation report - 2010. J Heart Lung Transplant 2010; 29: 1083-1141.
4. Note - infancy is defined as the first year of life. For purposes of this article we will use newborn to refer to infants in the first 30 days of life. When we are discussing infants without comparing them to newborns, then we are referring to patients from 0 through 365 days of life. When newborns are contrasted with infants, then infants will refer to those patients from 31 through 365 days of life.
5. Zuppan CW, Wells LM, Kerstetter JC, Johnston JK, Bailey LL, Chinnock RE. Cause of death in pediatric and infant heart transplant recipients: Review of a 20-year, single-institution cohort. J Heart Lung Transplant 2009; 28: 579-84.
6. Singh TP, Faber C, Blume ED, et al. Safety and early outcomes using a corticosteroid-avoidance Immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant 2010; 29(5): 517-522.
7. Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006; 367: 233-9.
8. Manlhiot C, Pollock-BarZiv SM, Holmes C, et al. J Heart Lung Transplant 2010; 29: 648-57.
9. Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983; 308: 23-26.
10. Bailey LL, Nehlsen-Cannarella S, Doroshow R, et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. New Engl J Med 1986; 315: 949-951.
11. Bove EL. Current status of staged reconstruction for hypoplastic left heart syndrome. Pediatr Cardiol 1998; 19: 308-15.
12. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002; 106 (suppl 1):1982-89.
13. Stasik CN, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg 2006; 13: 412-17.
14. Sano S, Ishino K, Kawada M, et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003; 126: 504-09.
15. Hasaniya NW, Razzouk AJ, Mulla NF, Larsen RL. In situ pericardial extracardiac lateral tunnel Fontan operation: Fifteen-year experience. J Thorac Cardiovasc Surg 2010; 140: 1076-83.
16. Delmo WEM, Hubler M, Alexi-Meskishvili V, et al. Staged surgical palliation in hypoplastic left heart syndrome and its variants. J Card Surg 2009; 24: 383-91.
17. Lamour JM, Kanter KR, Naftel DC, et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009; 54: 160-5.
18. del Nido P, Bailey LL, Kirklin JK. Surgical Techniques in Pediatric Heart Transplantation. In: Canter CE, Kirklin JK (eds). ISHLT Monograph Series 2, Pediatric Heart Transplantation. Philadelphia: Elsevier; 2007; 83-102.
19. Bailey LL. Heart transplantation techniques in complex congenital heart disease. J Heart Lung Transplant 1993; 12: S168-75.
20. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation 2006; 114: 273-80.
21. Jacobs JP, Quintessenza JA, Boucek RJ, et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004; 78: 1703-09.
22. Feingold B, Bowman P, Zeevi A, et al. Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant 2007; 26: 565-71.
23. Galantowicz M, Cheatham JP, Phillips A, et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 2008; 85: 2063-70.
24. Pizarro C, Murdison KA, Derby CD, Radtke W. Stage II reconstruction after hybrid palliation for high-risk patients with a single ventricle. Ann Thorac Surg 2008; 85: 1382-88.
25. Bacha EA, Daves S, Hardin J, et al. Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage I strategy. J Thorac Cardiovasc Surg 2006; 131: 163-8.
26. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart trasnplantation in the United States. Circulation 2009; 119: 717-27.
27. Mah D, Singh TP, Thiagarajan RR, et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant 2009; 28: 1291-8.
28. Boucek MM, Kanakriyeh MS, Mathis CM, Trimm RF 3rd, Bailey LL. Cardiac transplantation in infancy: donors and recipients. Loma Linda University Pediatric Heart Transplant Group. J Pediatr 1990; 116: 171-6.
29. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321-9.
30. Moon RY, Horne RSC, Hauck FR. Sudden infant death syndrome. Lancet 2007; 370: 1578-87.
31. Department of Transportation (US), National Highway Traffic Safety Administration (NHTSA), Traffic Safety Facts 2006: Children. Washington (DC): NHTSA; 2008. Available from: http://www.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810618.pdf
32. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Division of Vital Statistics. National Vital Statistics Reports. 2009; 57: 1-136.
33. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABOincompatible heart transplantation in infants. N Engl J Med 2001; 344: 793-800.
34. Dipchand AI, Pollock Barziv SM, Manlhiot C, West LJ, VanderVliet M, McCrindle BW. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010; 10: 389-97.
35. Saczkowski R, Dacey C, Bernier PL. Does ABO-incompatible and ABO-incompatible neonatal heart transplant have equivalent survival? Interac Cardiovasc Thorac Surg 2010; 10: 1026-33.
36. Almond CS, Gauvreau K, Thiagarajan RR, et al. Impact of ABOincompatible listing on wait-list outcomes among infants listed for heart transplantation in the Unites States - A propensity analysis. Circulation 2010; 121: 1926-33.
37. Urschel S, Campbell PM, Meyer SR, et al. Absence of donorspecific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant 2010; 10:149-56.
38. Boucek MM, Mashburn C, Dunn SM, et al. Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med 2008; 359: 709-14.
39. Mathur M, Castleberry D, Job L. Identifying potential heart donors among newborns undergoing circulatory determination of death. J Heart Lung Transplant - In Press.
40. Carcillo JA, Orr R, Bell M, et al. A call for full public disclosure and moratorium on donation after cardiac death in children. Pediatr Crit Care Med 2010; 11: 641-3.
41. Bailey LL, Razzouk AJ, Hasiniya NW, Chinnock RE. Pediatric transplantation using hearts refused on the basis of donor quality. Ann Thorac Surg 2009; 87: 1902-9.
42. Billingham RE, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
43. Platt JL, Rubinstein P. Mechanisms and characteristics of allograft rejection. In: Sabiston DC Jr, Lyerly HK, eds. Textbook of Surgery The Biological Basis of Modern Surgical Practice, 15 edn. Orlando: Textbook of Surgery, 1997; 400-8.
44. Burnet FM. The Clonal Selection Theory of Acquired Immunity. Nashville, TN: Vanderbilt University Press; 1959.
45. White DJ, Gilks W. The ontogeny of immune responses. J Heart Lung Transplant 1993; 12(6 pt 2): S301-8.
46. Platt JL, Cascalho M, West L. Lessons from cardiac transplantation in infancy. Pediatr Transplantation 2009; 13: 814-9.
47. Ogle BM, West LJ, Driscoll DJ, et al. Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol 2006; 176: 1962-7
48. Kulikowska A, Boslaugh SE, Huddleston CB, Gandhi SK, Gumbiner C, Canter CE. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients. J Pediatr 2008; 152: 671-7.